Firm Heterogeneity in Biotech: Absorptive Capacity, Strategies and Local-Regional Connections

Sharmistha Bagchi-Sen and Helen Lawton Smith

European Planning Studies, 2014, vol. 22, issue 9, 1783-1801

Abstract: This paper focuses on the characteristics of biotech firms with various levels of research and development (R&D) activity. It is done by exploring the relationship between R&D intensity, alliances and the extent of regionalization of firms' activities using evidence from a survey of US-based biotechnology firms. We profile two firm prototypes: research-oriented firms and product-oriented firms, focusing on their characteristics, strategies and operations. These include activities devoted to exploration and exploitation through alliances with universities (more exploration) and with pharmaceutical companies (exploration and exploitation), and locational needs which facilitate both exploration and exploitation.

Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/09654313.2013.801572 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:eurpls:v:22:y:2014:i:9:p:1783-1801

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CEPS20

DOI: 10.1080/09654313.2013.801572

Access Statistics for this article

European Planning Studies is currently edited by Philip Cooke and Louis Albrechts

More articles in European Planning Studies from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().